Voyager Therapeutics, Inc. SEC filings VYGR
Voyager Therapeutics, Inc. has 681 filings in SEC EDGAR's recent list, going back to Apr 23, 2015. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 21, 2026 (officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Dec 1, 2025 | — |
| CORRESP | Letter to the SEC | Nov 26, 2025 | — |
| D | Filing | Jan 17, 2024 | — |
| D | Filing | Mar 3, 2023 | — |
| EFFECT | Filing | Nov 15, 2022 | — |
| CORRESP | Letter to the SEC | Nov 10, 2022 | — |
| UPLOAD | Letter from the SEC | Nov 9, 2022 | — |
| CT ORDER | Filing | Feb 25, 2022 | — |
| SEC STAFF LETTER | Filing | Apr 19, 2021 | — |
| SEC STAFF LETTER | Filing | Mar 22, 2021 | — |
| EFFECT | Filing | Dec 2, 2019 | — |
| CORRESP | Letter to the SEC | Nov 27, 2019 | — |
| CORRESP | Letter to the SEC | Nov 22, 2019 | — |
| UPLOAD | Letter from the SEC | Nov 19, 2019 | — |
| CT ORDER | Filing | Mar 19, 2019 | — |
| CT ORDER | Filing | Apr 5, 2018 | — |
| EFFECT | Filing | Dec 20, 2016 | — |
| CORRESP | Letter to the SEC | Dec 20, 2016 | — |
| CORRESP | Letter to the SEC | Dec 19, 2016 | — |
| UPLOAD | Letter from the SEC | Dec 19, 2016 | — |
| POS EX | Filing | Nov 12, 2015 | — |
| EFFECT | Filing | Nov 10, 2015 | — |
| CERTNAS | Auto-generated paper document | Nov 10, 2015 | — |
| CT ORDER | Filing | Nov 10, 2015 | — |
| CORRESP | Letter to the SEC | Nov 6, 2015 | — |
| CORRESP | Letter to the SEC | Nov 6, 2015 | — |
| 8-A12B | Filing | Nov 6, 2015 | — |
| CORRESP | Letter to the SEC | Oct 16, 2015 | — |
| CORRESP | Letter to the SEC | Oct 9, 2015 | — |
| UPLOAD | Letter from the SEC | Sep 15, 2015 | — |
| DRSLTR | Filing | Aug 28, 2015 | — |
| DRS/A | Filing | Aug 28, 2015 | — |
| UPLOAD | Letter from the SEC | Jul 28, 2015 | — |
| DRSLTR | Filing | Jul 21, 2015 | — |
| DRS/A | Filing | Jul 21, 2015 | — |
| UPLOAD | Letter from the SEC | Jul 15, 2015 | — |
| DRS/A | Filing | Jun 29, 2015 | — |
| DRSLTR | Filing | Jun 26, 2015 | — |
| DRSLTR | Filing | Jun 19, 2015 | — |
| DRS | Filing | Jun 19, 2015 | — |
| D | Filing | Apr 23, 2015 | — |
Showing 41 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- VYGR (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Lexington, MA
- SEC filer status
- Accelerated filer, Smaller reporting company
- SEC CIK
- 1640266
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.